nifedipine has been researched along with Atrial Fibrillation in 23 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Excerpt | Relevance | Reference |
---|---|---|
"The possible kinetic and hemodynamic interactions between digoxin and nifedipine were evaluated in nine patients with atrial fibrillation who were receiving chronic digoxin." | 9.05 | Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation. ( Breimer, DD; Hillers, J; Kleinbloesem, CH; Moolenaar, AJ; van Brummelen, P, 1985) |
"The possible kinetic and hemodynamic interactions between digoxin and nifedipine were evaluated in nine patients with atrial fibrillation who were receiving chronic digoxin." | 5.05 | Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation. ( Breimer, DD; Hillers, J; Kleinbloesem, CH; Moolenaar, AJ; van Brummelen, P, 1985) |
" Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease." | 4.77 | Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985) |
" The pharmacokinetics of verapamil and of one of its metabolites, norverapamil, is changed after multiple oral dosing as has been described in patients with supraventricular tachyarrhythmias, angina pectoris or in patients with essential hypertension." | 3.76 | Pharmacokinetics of calcium channel blocking agents. ( Anderson, P, 1986) |
"In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62." | 2.67 | [Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure]. ( Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K, 1990) |
" From the investigations to date, changing the digoxin dosage prior to initiating calcium antagonist therapy is, however, not justifiable." | 2.38 | [Interaction between calcium antagonists and digoxin]. ( Christensen, C, 1991) |
"Paroxysmal atrial fibrillation is described in a patient that was consistent with the clinical history developed after induction of coronary artery spasm." | 1.31 | Coronary artery spasm-induced paroxysmal atrial fibrillation--a case report. ( Cherng, WJ; Hung, MJ; Kuo, LT; Wang, CH, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (21.74) | 18.7374 |
1990's | 6 (26.09) | 18.2507 |
2000's | 8 (34.78) | 29.6817 |
2010's | 4 (17.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vaccaro, W | 1 |
Huynh, T | 1 |
Lloyd, J | 1 |
Atwal, K | 1 |
Finlay, HJ | 1 |
Levesque, P | 1 |
Conder, ML | 1 |
Jenkins-West, T | 1 |
Shi, H | 1 |
Sun, L | 1 |
Du, H | 1 |
Fan, J | 1 |
Ling, Z | 1 |
Woo, K | 1 |
Su, L | 1 |
Chen, S | 1 |
Liu, Z | 1 |
Lan, X | 1 |
Zhou, B | 1 |
Xu, Y | 1 |
Chen, W | 1 |
Xiao, P | 1 |
Yin, Y | 1 |
Rietdorf, K | 1 |
Bootman, MD | 1 |
Sanderson, MJ | 1 |
Pollak, PT | 1 |
Cheung, CS | 1 |
Li, TK | 1 |
Lee, CP | 1 |
Burashnikov, A | 1 |
Antzelevitch, C | 1 |
Sosunov, EA | 1 |
Anyukhovsky, EP | 1 |
Hefer, D | 1 |
Rosen, TS | 1 |
Danilo, P | 1 |
Janse, MJ | 1 |
Rosen, MR | 1 |
Otterstad, JE | 1 |
Kirwan, BA | 1 |
Lubsen, J | 1 |
De Brouwer, S | 1 |
Fox, KA | 1 |
Corell, P | 1 |
Poole-Wilson, PA | 1 |
Parasuraman, R | 1 |
Gandhi, MM | 1 |
Liversedge, NH | 1 |
Ugwumadu, A | 1 |
Zipes, DP | 1 |
Gilmour, RF | 1 |
Fedor, JM | 1 |
Stack, RS | 1 |
Pryor, DB | 1 |
Phillips, HR | 1 |
Tanne, D | 1 |
Reicher-Reiss, H | 1 |
Boyko, V | 1 |
Behar, S | 1 |
Sharma, CD | 1 |
Caracciolo, EA | 1 |
Underwood, D | 1 |
Kern, MJ | 1 |
Van Wagoner, DR | 1 |
Pond, AL | 1 |
Lamorgese, M | 1 |
Rossie, SS | 1 |
McCarthy, PM | 1 |
Nerbonne, JM | 1 |
Hung, MJ | 1 |
Wang, CH | 1 |
Kuo, LT | 1 |
Cherng, WJ | 1 |
Workman, AJ | 1 |
Kane, KA | 1 |
Rankin, AC | 1 |
Christensen, C | 1 |
Bechler-Lisińska, J | 1 |
Cholewa, M | 1 |
Górski, L | 1 |
Markiewicz, K | 1 |
Anderson, P | 1 |
Winniford, MD | 1 |
Hillis, LD | 1 |
Kleinbloesem, CH | 1 |
van Brummelen, P | 1 |
Hillers, J | 1 |
Moolenaar, AJ | 1 |
Breimer, DD | 1 |
4 reviews available for nifedipine and Atrial Fibrillation
Article | Year |
---|---|
Calcium antagonists and their potential role in the prevention of sudden coronary death.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Calcium Chan | 1982 |
[Interaction between calcium antagonists and digoxin].
Topics: Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diltiazem; Drug Interactions; Humans; Nifedi | 1991 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; C | 1986 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio | 1985 |
5 trials available for nifedipine and Atrial Fibrillation
Article | Year |
---|---|
Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Press | 2013 |
Stroke risk after anterior wall acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Aged; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Female; Follow-Up Studies; Hu | 1995 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; C | 1986 |
Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dose-Response Relationship, Dru | 1985 |
15 other studies available for nifedipine and Atrial Fibrillation
Article | Year |
---|---|
Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)).
Topics: Animals; Atrial Fibrillation; Cell Line; Chemistry, Pharmaceutical; Drug Design; Humans; Ions; Mice; | 2008 |
Spontaneous, pro-arrhythmic calcium signals disrupt electrical pacing in mouse pulmonary vein sleeve cells.
Topics: Action Potentials; Animals; Atrial Fibrillation; Caffeine; Calcium Signaling; Electric Stimulation; | 2014 |
Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports.
Topics: Aged; Atrial Fibrillation; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Fe | 2010 |
Maternal atrial fibrillation after sequential use of nifedipine and atosiban for treatment of preterm labor: case report.
Topics: Adult; Atrial Fibrillation; Drug Therapy, Combination; Female; Humans; Nifedipine; Obstetric Labor, | 2013 |
Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity.
Topics: Acetylcholine; Action Potentials; Animals; Atrial Fibrillation; Atrial Function; Calcium Channel Blo | 2003 |
Region-specific, pacing-induced changes in repolarization in rabbit atrium: an example of sensitivity to the rare.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Apamin; Atrial Fibrillation; Atropine; Calc | 2005 |
Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease.
Topics: Aged; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Disease; Female; Humans; Incide | 2006 |
Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion.
Topics: Adult; Atrial Fibrillation; Electric Countershock; Female; Humans; Nifedipine; Obstetric Labor, Prem | 2006 |
Nifedipine-tocolysis-associated atrial fibrillation responds to DC cardioversion.
Topics: Atrial Fibrillation; Calcium Channel Blockers; Electric Countershock; Female; Humans; Nifedipine; Pr | 2007 |
Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Topics: Atrial Fibrillation; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiomyopathy, Hyper | 1983 |
Atrial fibrillation with hypertensive crisis.
Topics: Atrial Fibrillation; Electrocardiography; Furosemide; Humans; Hypertension; Male; Middle Aged; Nifed | 1994 |
Attenuation of hypertensive-induced pulsus alternans by nifedipine and nitroglycerin.
Topics: Administration, Sublingual; Aged; Aortic Valve Stenosis; Atrial Fibrillation; Blood Pressure; Cardia | 1994 |
Atrial L-type Ca2+ currents and human atrial fibrillation.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Ca | 1999 |
Coronary artery spasm-induced paroxysmal atrial fibrillation--a case report.
Topics: Atrial Fibrillation; Coronary Angiography; Coronary Vasospasm; Electrocardiography, Ambulatory; Fema | 2001 |
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation.
Topics: 4-Aminopyridine; Action Potentials; Aged; Atrial Fibrillation; Atrial Function; Calcium Channel Bloc | 2001 |